Analystreport

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies.

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors